LGC acquires Axolabs

London (3 April 2017) – LGC today announced that it has acquired Axolabs, a leading Contract Research, Development and Manufacturing Organisation, specialising in the development of therapeutic nucleic acids (TNAs).


Lab space expansion for GLP/GCP

We have recently expanded our facility with 400 square meters of additional laboratories and offices and purchased state-of-the-art equipment. This new facility is dedicated to our services performed under the standards of GLP/GCP.